Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Immunology

Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging

Nemil Shah, Guihua Zhai, Joseph Knowles, Cecil Stockard, William Grizzle, Naomi Fineberg, Tong Zhou, Kurt Zinn, Eben Rosenthal and Hyunki Kim
Nemil Shah
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guihua Zhai
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Knowles
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecil Stockard
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Grizzle
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Fineberg
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tong Zhou
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Zinn
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eben Rosenthal
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyunki Kim
1Univ. of Alabama at Birmingham, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2011-1795 Published April 2011
  • Article
  • Info & Metrics
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2014 to February 2021

AbstractFull-text HTMLPDF
Total382068

Cited By

Article Information

Volume 71, Issue 8 Supplement, pp. 1795

DOI 
https://doi.org/10.1158/1538-7445.AM2011-1795

Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445

Copyright & Usage 
©2011 American Association for Cancer Research

Author Information

  1. Nemil Shah1,
  2. Guihua Zhai1,
  3. Joseph Knowles1,
  4. Cecil Stockard1,
  5. William Grizzle1,
  6. Naomi Fineberg1,
  7. Tong Zhou1,
  8. Kurt Zinn1,
  9. Eben Rosenthal1, and
  10. Hyunki Kim1
  1. 1Univ. of Alabama at Birmingham, Birmingham, AL.
Back to top
Cancer Research: 71 (8 Supplement)
April 2011
Volume 71, Issue 8 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging
Nemil Shah, Guihua Zhai, Joseph Knowles, Cecil Stockard, William Grizzle, Naomi Fineberg, Tong Zhou, Kurt Zinn, Eben Rosenthal and Hyunki Kim
Cancer Res April 15 2011 (71) (8 Supplement) 1795; DOI: 10.1158/1538-7445.AM2011-1795

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging
Nemil Shah, Guihua Zhai, Joseph Knowles, Cecil Stockard, William Grizzle, Naomi Fineberg, Tong Zhou, Kurt Zinn, Eben Rosenthal and Hyunki Kim
Cancer Res April 15 2011 (71) (8 Supplement) 1795; DOI: 10.1158/1538-7445.AM2011-1795
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Immunology

  • Abstract 6703: A fully synthetic EphA2/4-1BB tumor-targeted immune cell agonist (TICATM) induces tumor localized 4-1BB agonism
  • Abstract 6686: SO-C101 displays strong anti-tumor effect in TC-1 and TRAMP-C2 tumor mice and in combination with PD-1 blockade prevents tumor development in a NK and CD8+ T cells dependent manner
  • Abstract 6621: A combined VHH and small molecule approach to modulate the antitumor immunity function of ERAP1
Show more Immunology

Poster Presentations - Proffered Abstracts

  • Abstract 6703: A fully synthetic EphA2/4-1BB tumor-targeted immune cell agonist (TICATM) induces tumor localized 4-1BB agonism
  • Abstract 6686: SO-C101 displays strong anti-tumor effect in TC-1 and TRAMP-C2 tumor mice and in combination with PD-1 blockade prevents tumor development in a NK and CD8+ T cells dependent manner
  • Abstract 6621: A combined VHH and small molecule approach to modulate the antitumor immunity function of ERAP1
Show more Poster Presentations - Proffered Abstracts

Poster Presentations - Novel Combination Immunotherapy Approaches and New Agents

  • Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2
  • Abstract 1802: Genomic changes elicited by mitomycin C that confer increased sensitivity of peritoneal cancer cells to death ligands
  • Abstract 1786: Improved survival with gemcitabine and CTLA-4 blockade in a murine model of prostate cancer
Show more Poster Presentations - Novel Combination Immunotherapy Approaches and New Agents
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement